BackgroundCheck.run
Search For

George J Griesgraber Deceased1085 Goodrich Ave, Saint Paul, MN 55105

George Griesgraber Phones & Addresses

1085 Goodrich Ave, Saint Paul, MN 55105   

Las Vegas, NV   

Social networks

George J Griesgraber
George J Griesgraber

Linkedin

Work

Company: 3m Jul 2011 Position: Senior research specialist

Education

School / High School: University of Minnesota-Twin Cities 1984 to 1994

Industries

Research

Mentions for George J Griesgraber

George Griesgraber resumes & CV records

Resumes

George Griesgraber Photo 11

Senior Research Specialist At 3M

Position:
Senior Research Specialist at 3M
Location:
Greater Minneapolis-St. Paul Area
Industry:
Research
Work:
3M since Jul 2011
Senior Research Specialist
3M Jun 2010 - Jul 2011
Advanced Research Specialist
3M Feb 2007 - Jun 2010
Advanced Research Specialist
3M Apr 2005 - Feb 2007
Advanced Research Specialist
3M Mar 2002 - Apr 2005
Resaerch Specialist
3M Jul 2000 - Mar 2002
Senior Research Chemist
Abbott Laboratories 1994 - 1997
Research Chemist
Education:
University of Minnesota-Twin Cities 1984 - 1994

Publications & IP owners

Us Patents

Nucleosides With Antiviral And Anticancer Activity

US Patent:
6475985, Nov 5, 2002
Filed:
Sep 27, 2000
Appl. No.:
09/647206
Inventors:
Carston R. Wagner - St. Paul MN
George W. Griesgraber - Eagan MN
Assignee:
Regents of the University of Minnesota - Minneapolis MN
International Classification:
A61K 3170
US Classification:
514 7, 514 8, 514 47, 514 48, 514 51, 514 52, 530322, 536 261, 536 267, 536 2674, 536 268, 536 269, 536 292
Abstract:
The invention provides nucleosides of formulae (I), (II), (V) and (VII) as described in the specification which possess antiviral and anticancer activity. Treatment of breast cancer is a preferred embodiment.

Urea Substituted Imidazoquinolines

US Patent:
6573273, Jun 3, 2003
Filed:
Dec 21, 2001
Appl. No.:
10/028255
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Kyle J. Lindstrom - Houlton WI
Bryon A. Merrill - River Falls WI
Michael J. Rice - Oakdale MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 34745
US Classification:
514293, 546 82, 544126, 5142325
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Urea Substituted Imidazoquinoline Ethers

US Patent:
6656938, Dec 2, 2003
Filed:
Dec 6, 2001
Appl. No.:
10/013060
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Bryon A. Merrill - River Falls WI
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
5142328, 514293, 544126, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and urea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Urea Substituted Imidazoquinoline Ethers

US Patent:
6660735, Dec 9, 2003
Filed:
Jun 7, 2002
Appl. No.:
10/164816
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Bryon A. Merrill - River Falls WI
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 315377
US Classification:
5142328, 514293, 544126, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and urea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Amido Ether Substituted Imidazoquinolines

US Patent:
6660747, Dec 9, 2003
Filed:
Dec 6, 2001
Appl. No.:
10/011670
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Bryon A. Merrill - River Falls MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
514293, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Heterocyclic Ether Substituted Imidazoquinolines

US Patent:
6664260, Dec 16, 2003
Filed:
Dec 6, 2001
Appl. No.:
10/011921
Inventors:
Leslie J. Charles - Hudson WI
Joseph F. Dellaria - Woodbury MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Karl J. Manske - Minneapolis MN
John W. Mickelson - Mattawan MI
Michael J. Rice - Oakdale MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
514256, 514293, 544333, 544242, 546 82, 546 64
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and heterocyclyl or heteroaryl functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Amido Ether Substituted Imidazoquinolines

US Patent:
6664265, Dec 16, 2003
Filed:
Jun 7, 2002
Appl. No.:
10/165449
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Byron A. Merrill - River Falls WI
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
514293, 546 82
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Sulfonamido Ether Substituted Imidazoquinolines

US Patent:
6677347, Jan 13, 2004
Filed:
Jun 7, 2002
Appl. No.:
10/165443
Inventors:
Stephen L. Crooks - Mahtomedi MN
George W. Griesgraber - Eagan MN
Philip D. Heppner - Woodbury MN
Bryon A. Merrill - River Falls WI
Ralph R. Roberts - Cottage Grove MN
Ai-Ping Wei - Woodbury MN
Assignee:
3M Innovative Properties Company - St. Paul MN
International Classification:
A61K 314745
US Classification:
514293, 546 82, 546 84, 546159
Abstract:
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.